In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Devices & Diagnostics

Division of Eli Lilly & Co.

Latest From Medical Devices & Diagnostics

New Zealand reclassifies glyceryl trinitrate for rectal use

New Zealand has reclassified glyceryl trinitrate from a pharmacy to a pharmacist-only medicine when used rectally.

New Zealand Approvals

New Zealand's e-ADR tool sees 50% of GPs on board

New Zealand's electronic adverse drug reaction (ADR) tool, one of first in the world to deliver e-ADR reports directly from doctors, has been widely accepted since its launch in May.

New Zealand Post Market Regulation & Studies

New Zealand warns doctors about internet medicines

The New Zealand Medicines and Medical Devices Safety Authority ( Medsafe) has warned doctors about writing prescriptions to enable the release of medicines held at the New Zealand border, which have been ordered by patients. The internet has become a popular route for patients to obtain prescription medicines, which can come from unregulated markets.

New Zealand

Germany must change its stem cell law to benefit from this innovative technology

Germany’s insistence on finding a consensus on embryonic stem cell research and its ban on the use of home-grown cell lines are hampering its ability to keep pace with other high- technology countries in this field. The stakes have been raised even higher of late, as US President Barack Obama has reversed the policy of the Bush era, and lifted the ban on stem cell research funding. But the barriers to success for German researchers in this area are simultaneously legal, ethical and religious in nature.

Sweden
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eli Lilly & Co.
  • Senior Management
  • Ronald W Dollens, Pres.
  • Contact Info
  • Medical Devices & Diagnostics
    Phone: (317) 276-3655
    Indianapolis, IN 46285
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register